Ortho-Cyclen tablets had sales of $204 million.
AB Wire
Lupin has launched its Norgestimate and Ethinyl Estradiol tablets USP, 0.25 mg/0.035 mg in the US, having received approval from United States Food and Drug Administration (FDA) earlier to market a generic version of Janssen Pharmaceuticals, Inc’s Ortho-Cyclen 28 Tablets (Norgestimate/Ethinyl Estradiol), reported The Times of India.
Ortho-Cyclen tablets had sales of $204 million, according to IMS MAT September 2016.
Lupin has the fifth largest pipeline of ANDA filings pending approval with USFDA – 136 product filings pending approval, says a company statement.
Cumulative Filings with USFDA now stand at 345, with the company having received approvals for 209 products, the Times of India report added.